Inailico Medicine opens AI longevity discovery toolkit to researchers worldwide in cell cover study
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Oct-2026 14:16 ET (23-Oct-2026 18:16 GMT/UTC)
The paper introduces three interconnected resources for the global scientific community:
LongevityBench, the first open benchmark designed to rigorously evaluate AI reasoning across multiple domains of aging biology;
Longevity-LLMs, a family of compact, open-source language models specifically trained on clinical and multi-omics aging data; and
Longevity Claw, an open-source agentic research platform that autonomously integrates specialized longevity tools to identify and prioritize potential therapeutic targets.
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified candidate treatment targets and potential prognostic markers for high-grade glioma, an aggressive brain cancer, in children, adolescents, and young adults. The study found that high-grade glioma varies by developmental stage and sex, showing distinct tumor biology and outcomes across patient groups. Using this information to guide clinical trial design and develop new therapies could advance more precise treatment strategies. The findings were published in Cell Reports Medicine.
About the Study: Intrauterine instillation of 10 mL of mepivacaine (20 mg/mL) significantly reduced pain and improved tolerability during IUD placement compared with instillation of placebo saline.
In this multicenter randomized clinical trial of 370 nulliparous individuals undergoing placement of smaller-diameter IUDs, intrauterine instillation of mepivacaine reduced pain during IUD placement compared with placebo saline and improved tolerability. The findings support mepivacaine instillation as a simple approach that could improve the IUD placement experience.
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
SUNY College of Optometry Foundation announced the speakers, topics, and agenda for the inaugural Advancing Vision Summit: The Intersection of AI, Eye Care, and Public Health, a free, day-long event on Friday, September 25 that will bring together leaders in health care, technology, public health, research, and optometry to explore the future of eye care and its role in improving broader health outcomes.
With an $11 million award from the National Institute on Aging, University of Michigan researchers will build and share national data that track how neighborhood conditions change over time, helping scientists study how local environments affect older adults' health.